Value Communication Archives

Market Access Trends 2026

How Four Pillars Are Shaping Latin America and MENA Market Access

March 25, 2026

Latin American and MENA markets have long faced the challenge of balancing constrained public budgets with rising demand for newer therapies. In 2025, governments in these regions took concrete steps to modernize pricing rules, raise evidence expectations, expand partnership models, and...

Market Access Trends 2026

How Regulatory–HTA Convergence Is Reshaping European Market Access

March 24, 2026

Across Europe, 2025 accelerated a shift from sequential regulatory and access steps to more connected process through the Joint Clinical Assessment. Regulatory approvals, and clinical portion of HTA evaluation are now more tightly linked, which has the potential to bring the...

Market Access Trends 2026

How MFN and Direct-to-Consumer Models Are Rewiring US Market Access

March 23, 2026

Globally, 2025 marked a shift from debating drug pricing policy to implementing it. Pricing pressure intensified, evidence expectations rose, and long-standing access models began to change amid political and fiscal realities. In Trinity’s webinar “Around the World in Market Access 2026:...

Blog

Seizing the Storm: Why Pharma Must Plan, Not Panic in Trump’s Second Term

April 29, 2025

The first 100 days of President Trump’s return to the White House have been anything but ordinary. With a true “Flood the Zone” strategy, there has been a flurry of executive orders, leadership reshuffles, and a re-assertion of executive power, which...

Blog

Learnings to Kick-Start 2025: Joint Clinical Assessments and Health Technology Assessments

January 17, 2025

One trend Trinity Life Sciences has observed and that was reinforced by stakeholders at ISPOR EU is the importance of evidence in healthcare decision-making. This trend was highlighted particularly in the context of joint clinical assessments (JCA) and health technology assessments...

Blog

Developing Effective Global Value Dossiers

June 13, 2024

Trinity Life Sciences recently worked with a large global pharma company to develop a new process for creating global value dossiers (GVDs) that better met the needs of regional affiliates. Matt O’Hara, who leads Trinity’s Evidence Strategy practice, shares insights into...